Impact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study
Authors:
- Etienne ChazalECEtienne Chazal
- Lucas MorinLMLucas Morin
- Sidney ChocronSCSidney Chocron
- Philippe LassallePLPhilippe Lassalle
- Sebastien Pili-FlourySPSebastien Pili-Floury
- Lucie Salomon du MontLMLucie Salomon du Mont
- David FerreiraDFDavid Ferreira
- Emmanuel SamainESEmmanuel Samain
- Andrea PerrottiAPAndrea Perrotti
- Guillaume BeschGBGuillaume Besch
Open Access
- 24 August 2023
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-8
Abstract
Background: Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperative glycemic variability and endothelial function, as assessed by serum endocan level in cardiac surgery patients. Methods: We performed a post hoc analysis of patients included in the single-center observational ENDOLUNG study. Adult patients who underwent planned isolated coronary artery bypass graft surgery were eligible. Postoperative glycemic variability was assessed by calculating the coefficient of variability (CV) of blood glucose measured within 24 (CV24) and 48 (CV48) hours after surgery. Serum endocan level was measured at 24 (Endocan24) and 48 (Endocan48) hours after surgery. Pearson’s correlation coefficient with 95% confidence interval (95% CI) was calculated between CV24 and Endocan24, and between CV48 and Endocan48. Results: Data from 177 patients were analyzed. Median CV24 and CV48 were 18% (range 7 to 39%) and 20% (range 7 to 35%) respectively. Neither CV48 nor CV24 were significantly correlated to Endocan48 and Endocan24 respectively (r (95% CI) = 0.150 (0.001 to 0.290; and r (95% CI) = 0.080 (-0.070 to 0.220), respectively). Conclusions: Early postoperative glycemic variability within 48 h after planned cardiac surgery does not appear to be correlated with postoperative serum endocan level. Clinical trial registration number: NCT02542423.Keywords
This publication has 33 references indexed in Scilit:
- Serum Endothelial Cell–Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical SignificanceAngiology, 2016
- Relationship of Endothelial Cell–Specific Molecule 1 Level in Stress Hyperglycemia Patients With Acute ST-Segment Elevation Myocardial InfarctionAngiology, 2016
- Effect of Glycemic Regulation on Endocan Levels in Patients With DiabetesAngiology, 2015
- Increased Glycemic Variability in Patients with Elevated Preoperative HbA1C Predicts Adverse Outcomes Following Coronary Artery Bypass Grafting SurgeryAnesthesia & Analgesia, 2014
- Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patientsCritical Care Medicine, 2012
- Role of Intraoperative and Postoperative Blood Glucose Concentrations in Predicting Outcomes after Cardiac SurgeryAnesthesiology, 2010
- Efficacy and safety of an insulin infusion protocol during and after cardiac surgeryDiabetes & Metabolism, 2010
- Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic PatientsDiabetes, 2008
- Cytokine secretion after cardiac surgery and its relationship to postoperative feverCytokine, 2007
- Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 DiabetesJAMA, 2006